These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20961217)

  • 1. Investigation of kinetics of methotrexate for therapeutic treatment of intraocular lymphoma.
    Palakurthi NK; Krishnamoorthy M; Augsburger JJ; Correa ZM; Banerjee RK
    Curr Eye Res; 2010 Dec; 35(12):1105-15. PubMed ID: 20961217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local methotrexate and dexamethasone phosphate for the treatment of recurrent primary intraocular lymphoma.
    Velez G; Boldt HC; Whitcup SM; Nussenblatt RB; Robinson MR
    Ophthalmic Surg Lasers; 2002; 33(4):329-33. PubMed ID: 12134997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity of a biodegradable microneedle implant loaded with methotrexate as a sustained release device in normal rabbit eye: a pilot study.
    Palakurthi NK; Correa ZM; Augsburger JJ; Banerjee RK
    J Ocul Pharmacol Ther; 2011 Apr; 27(2):151-6. PubMed ID: 21323470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary intraocular lymphoma invaded to the central nervous system after successful treatment with intraocular methotrexate injection].
    Watanabe K; Arai A; Takase H; Takahashi H; Iwanaga Y; Sugamoto Y; Sugita S; Mochizuki M; Miura O
    Rinsho Ketsueki; 2009 Mar; 50(3):182-6. PubMed ID: 19352085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of primary intraocular lymphoma (PIOL) has involved systemic, intravitreal or intrathecal chemotherapy and/or radiotherapy.
    Itty S; Olson JH; O'Connell DJ; Pulido JS
    Retina; 2009 Mar; 29(3):415-6. PubMed ID: 19174721
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.
    Frenkel S; Hendler K; Siegal T; Shalom E; Pe'er J
    Br J Ophthalmol; 2008 Mar; 92(3):383-8. PubMed ID: 18303160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose methotrexate for intraocular lymphoma.
    Batchelor TT; Kolak G; Ciordia R; Foster CS; Henson JW
    Clin Cancer Res; 2003 Feb; 9(2):711-5. PubMed ID: 12576439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma.
    Velez G; Yuan P; Sung C; Tansey G; Reed GF; Chan CC; Nussenblatt RB; Robinson MR
    Arch Ophthalmol; 2001 Oct; 119(10):1518-24. PubMed ID: 11594954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement.
    Smith JR; Rosenbaum JT; Wilson DJ; Doolittle ND; Siegal T; Neuwelt EA; Pe'er J
    Ophthalmology; 2002 Sep; 109(9):1709-16. PubMed ID: 12208721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cases of primary intraocular lymphoma: fine needle aspiration diagnosis and intravitreal methotrexate treatment.
    Zhao T; Li Y; Tang L; Wei X; Zhu X
    J Huazhong Univ Sci Technolog Med Sci; 2011 Feb; 31(1):142-144. PubMed ID: 21336740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable chitosan and polylactic acid-based intraocular micro-implant for sustained release of methotrexate into vitreous: analysis of pharmacokinetics and toxicity in rabbit eyes.
    Manna S; Banerjee RK; Augsburger JJ; Al-Rjoub MF; Donnell A; Correa ZM
    Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1297-305. PubMed ID: 25896109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary intraocular lymphoma].
    Coupland SE; Heimann H
    Ophthalmologe; 2004 Jan; 101(1):87-98. PubMed ID: 14986704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of non Hodgkin's intraocular lymphoma with intravitreal methotrexate.
    de Smet MD
    Bull Soc Belge Ophtalmol; 2001; (279):91-5. PubMed ID: 11344720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma.
    Fishburne BC; Wilson DJ; Rosenbaum JT; Neuwelt EA
    Arch Ophthalmol; 1997 Sep; 115(9):1152-6. PubMed ID: 9298056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of chitosan and polylactic acid based methotrexate intravitreal micro-implants to treat primary intraocular lymphoma: an in vitro study.
    Manna S; Augsburger JJ; Correa ZM; Landero JA; Banerjee RK
    J Biomech Eng; 2014 Feb; 136(2):021018. PubMed ID: 24317155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical review: treatment of vitreoretinal lymphoma.
    Pe'er J; Hochberg FH; Foster CS
    Ocul Immunol Inflamm; 2009; 17(5):299-306. PubMed ID: 19831557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate delivery to the eye using transscleral hydrogel iontophoresis.
    Eljarrat-Binstock E; Domb AJ; Orucov F; Frucht-Pery J; Pe'er J
    Curr Eye Res; 2007; 32(7-8):639-46. PubMed ID: 17852187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and pharmacokinetics of intravitreal 2-methoxyestradiol implants in normal rabbit and pharmacodynamics in a rat model of choroidal neovascularization.
    Robinson MR; Baffi J; Yuan P; Sung C; Byrnes G; Cox TA; Csaky KG
    Exp Eye Res; 2002 Feb; 74(2):309-17. PubMed ID: 11950241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intravitreal chemotherapy for intraocular lymphoma].
    Helbig H; Cerny T; de Smet MD
    Ophthalmologe; 2003 Feb; 100(2):145-9. PubMed ID: 12589460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary intraocular lymphoma: A review.
    Choi JY; Kafkala C; Foster CS
    Semin Ophthalmol; 2006; 21(3):125-33. PubMed ID: 16912010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.